Monday, June 15, 2026

Kim Sung-tae’s Appeal: How North Korean Funds Impact His Trial

Kim Seong-tae seeks trial postponement in North Korea remittance case, citing ongoing parliamentary investigation affecting his appeal.

How KAIST’s New 2D Material Solves Long-Standing Issues in Electronic Conductivity

KAIST researchers developed a novel 2D conductive metal-organic framework, enhancing electron movement and addressing stacking issues.

North Korea Expresses Support for Myanmar’s Political Transition

North Korea welcomes Myanmar's political transition, hoping for stability, economic growth, and stronger regional ties post-elections.

Tag: cancer drug

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us